New UK NSC guidance explains how conflicts of interest can be mitigated
New UK NSC guidance explains how the committee decides if action is required to mitigate declared conflicts of interest by stakeholders and members.
English government endorses recommendation to screen newborns for tyrosinaemia
The English government has endorsed the UK National Screening Committee’s recommendation to add hereditary tyrosinaemia type 1 to the conditions screened for by the NHS Newborn Blood Spot Screening Programme.
SMA ISE clinical pathway expert sub-group meets for first time
SMA screening in-service evaluation clinical pathway group holds its first meeting.
Screening workstreams prominent in England Rare Diseases Action Plan
The UK National Screening Committee's (UK NSC's) work to improve the newborn screening evidence base features prominently in the England Rare Diseases Action Plan 2024.
Recent Comments